Pharmacist's Letter Canada | Convenient Monthly Updates + CE

Current Issue

January 2025 Issue

Brush Up on Biosimilars

You’ll see more Rxs for biosimilars...

Resources

FAQ: Facts About Biosimilars

CYP’n on Grapefruit Juice With Statins – Do We Still Avoid?

There’s still debate about whether patients should really avoid certain statins with grapefruit juice...

Know Where Topical Ruxolitinib Fits for Vitiligo and Eczema

Ruxolitinib (Opzelura) 1.5% cream will be the first topical JAK inhibitor for vitiligo and mild to moderate eczema in ages 12 and up...

Prepare for a New Formulation of Sildenafil

Sildenafil (Viagra) will be the first PDE5 inhibitor to come as an orodispersible film (ODF) for erectile dysfunction...

GO TO FULL ISSUE

CE & Training

INTERACTIVE SELF-STUDY CE: Supplements for Healthy Aging

CE-IN-THE-LETTER: Pharmacist's Letter Canada January 2025

LIVE CE: Pharmacy Essential Updates January 2025

PODCAST CE: Medication Talk - Natural Medicines Highlights

GO TO CE & TRAINING ORGANIZER >

Featured Clinical Resources

GO TO ALL CLINICAL RESOURCES >

What is Pharmacist's Letter Canada?

Pharmacist's Letter Canada is the resource trusted by over 200,000 pharmacists for staying current on medication recommendations and taking and tracking CE. Learn more >

Developing Your Pharmacy Career

Pharmacist's Letter Canada is one of many CE and training solutions from TRC Healthcare. We support pharmacists like you at all stages of their career. Learn more about:

Advanced Resources for Natural Medicines
Training on Diabetes Monitoring and Management for Pharmacists

Group Purchases & Pricing

Pharmacist’s Letter Canada is eligible for bulk discounts. Easily manage staff access and customize CE & training assignments. Bundle with other products for significant savings. Request information